Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NV › Las Vegas › NPI 1104870187
Hospital

Sunrise Mountainview Hospital, INC.

Sunrise Mountainview Hospital, INC. was paid $32.16M by Medicaid between Jan 2018 and Dec 2024, across 272 billing codes. Its largest line is 99283, emergency room visit (moderate) — 19% of everything it billed.

33Billing provider infoSUNRISE MOUNTAINVIEW HOSPITAL, INC.
LAS VEGAS, NV 89128
33aNPI1104870187assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$32.16M
24GClaims1,474,843
24DCodes billed272
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Nevada

Rank by total paid#6 of 36
Median peer was paid$7.64M
This provider vs. median4.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201860,189$1.55M
2019249,554$5.01M
2020223,263$4.42M
2021232,204$5.16M
2022236,559$5.88M
2023247,467$5.45M
2024incomplete225,607$4.69M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 19% 78,004 69,324 $6.00M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 18% 64,163 57,243 $5.89M
G0378 Hospital observation service, per hour 9.7% 18,577 10,137 $3.11M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 5.3% 17,744 15,650 $1.69M
74177 Computed tomography, abdomen and pelvis; with contrast material 4.2% 11,478 10,757 $1.35M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 3.8% 35,771 31,930 $1.21M
93975 2.7% 6,415 5,399 $877K
99282 Emergency department visit for the evaluation and management, low to moderate severity 2.7% 11,659 11,092 $856K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1.9% 4,132 1,417 $600K
71275 Computed tomographic angiography, chest, with contrast material 1.7% 3,848 3,571 $532K
71045 Radiologic examination, chest; single view 1.6% 36,595 32,230 $510K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.4% 17,049 13,799 $450K
260 more codes
96361 Intravenous infusion, hydration; each additional hour 1.3% 23,290 $421K
70450 Computed tomography, head or brain; without contrast material 1.3% 10,778 $416K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1.2% 14,882 $382K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1.1% 4,606 $360K
80053 Comprehensive metabolic panel 1.0% 53,523 $322K
71046 Radiologic examination, chest; 2 views <1% 14,031 $289K
76830 Ultrasound, transvaginal <1% 5,198 $285K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 3,379 $232K
93976 <1% 2,180 $230K
96375 Therapeutic injection; each additional sequential IV push <1% 22,200 $225K
85027 <1% 107,567 $223K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 2,520 $219K
72125 Computed tomography, cervical spine; without contrast material <1% 3,241 $214K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 4,827 $211K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 53,729 $208K
80048 Basic metabolic panel (calcium, ionized) <1% 37,956 $197K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 7,097 $187K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 3,362 $183K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 7,795 $173K
83880 <1% 11,937 $148K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 4,967 $146K
84484 <1% 35,055 $139K
80076 <1% 28,354 $122K
84703 <1% 34,574 $99K
83690 <1% 28,377 $94K
78492 <1% 454 $94K
93971 <1% 2,352 $93K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 2,549 $91K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 7,640 $88K
J7030 Infusion, normal saline solution , 1000 cc <1% 35,834 $85K
93970 <1% 1,254 $81K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,255 $81K
81001 <1% 43,926 $78K
87040 <1% 12,518 $76K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,251 $74K
G0383 Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 1,610 $73K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,167 $70K
73564 <1% 2,645 $65K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,482 $59K
80047 <1% 13,326 $59K
73130 <1% 3,068 $58K
74018 <1% 3,077 $57K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,196 $56K
84702 <1% 9,212 $55K
10060 <1% 630 $54K
87070 <1% 4,868 $52K
73610 <1% 2,434 $52K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 164 $50K
73630 <1% 2,987 $48K
12001 <1% 860 $47K
70486 <1% 637 $47K
97163 <1% 2,975 $44K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 3,663 $43K
87088 <1% 9,637 $42K
85730 <1% 25,320 $41K
A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries <1% 454 $40K
73110 <1% 1,726 $39K
73030 <1% 2,432 $38K
90715 <1% 1,411 $38K
81025 <1% 12,368 $38K
96376 <1% 6,674 $36K
82550 <1% 13,352 $35K
83605 <1% 7,836 $35K
85610 <1% 30,661 $35K
87210 <1% 7,171 $35K
0450 Emergency room services <1% 756 $34K
72100 <1% 2,110 $32K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 4,071 $30K
12011 <1% 519 $30K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,222 $28K
70491 <1% 293 $28K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 123 $27K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 1,262 $27K
87430 <1% 4,659 $27K
84443 Thyroid stimulating hormone (TSH) <1% 5,152 $27K
C1781 Mesh (implantable) <1% 115 $25K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,772 $25K
29125 <1% 448 $24K
93017 <1% 1,324 $23K
70496 <1% 153 $21K
73080 <1% 957 $21K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 8,932 $20K
Q0114 Fern test <1% 1,073 $19K
70551 Magnetic resonance imaging, brain; without contrast material <1% 228 $19K
J7120 Ringers lactate infusion, up to 1000 cc <1% 7,545 $19K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,024 $18K
83735 <1% 14,154 $18K
70498 <1% 132 $18K
86850 <1% 7,604 $18K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 27,751 $17K
87420 <1% 1,463 $17K
73502 <1% 927 $16K
50590 <1% 13 $14K
J7050 Infusion, normal saline solution, 250 cc <1% 10,594 $14K
82805 <1% 2,016 $13K
85379 <1% 3,846 $13K
73590 <1% 824 $12K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 1,744 $11K
83036 Hemoglobin; glycosylated (A1C) <1% 3,457 $11K
81003 <1% 9,354 $10K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 2,906 $10K
73090 <1% 668 $10K
86900 <1% 12,176 $10K
86901 <1% 12,178 $9K
J2270 Injection, morphine sulfate, up to 10 mg <1% 7,517 $9K
80061 Lipid panel <1% 2,731 $9K
72050 <1% 327 $8K
82140 <1% 1,860 $8K
82731 <1% 365 $8K
84439 <1% 2,708 $8K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,611 $8K
87186 <1% 2,691 $8K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 9,662 $7K
84112 <1% 804 $6K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 82 $6K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 20,917 $6K
J2791 Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu <1% 118 $6K
96368 <1% 1,143 $6K
76775 <1% 246 $6K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,558 $6K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,532 $5K
12002 <1% 93 $5K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,706 $5K
76870 <1% 228 $5K
86923 <1% 985 $5K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 123 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,674 $5K
72131 <1% 109 $5K
J3490 Unclassified drugs <1% 480 $5K
97167 <1% 613 $5K
J7999 Compounded drug, not otherwise classified <1% 1,341 $5K
J0780 Injection, prochlorperazine, up to 10 mg <1% 1,461 $4K
86140 <1% 2,463 $4K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 6,264 $4K
80069 <1% 3,459 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 560 $4K
77067 Screening mammography, bilateral, including computer-aided detection <1% 63 $4K
J0456 Injection, azithromycin, 500 mg <1% 1,750 $4K
P9016 Red blood cells, leukocytes reduced, each unit <1% 491 $4K
84100 <1% 6,801 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 3,921 $4K
82010 <1% 895 $3K
J2060 Injection, lorazepam, 2 mg <1% 3,894 $3K
90714 <1% 340 $3K
36430 <1% 248 $3K
J1630 Injection, haloperidol, up to 5 mg <1% 2,317 $3K
J1815 Injection, insulin, per 5 units <1% 3,642 $3K
J8540 Dexamethasone, oral, 0.25 mg <1% 2,186 $3K
85049 <1% 827 $3K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 229 $3K
J3370 Injection, vancomycin hcl, 500 mg <1% 541 $3K
J1790 Injection, droperidol, up to 5 mg <1% 1,023 $3K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,804 $3K
72072 <1% 146 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 34 $3K
88307 <1% 118 $2K
82570 <1% 928 $2K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 314 $2K
73562 <1% 109 $2K
82728 <1% 363 $2K
97597 <1% 57 $2K
87631 <1% 1,497 $2K
82553 <1% 361 $2K
71250 <1% 29 $2K
82248 <1% 2,520 $2K
83050 <1% 477 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 1,839 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,128 $2K
70487 <1% 13 $2K
85652 <1% 1,830 $2K
87077 <1% 712 $2K
82330 <1% 327 $1K
97116 <1% 406 $1K
S0028 Injection, famotidine, 20 mg <1% 3,476 $1K
77063 Screening digital breast tomosynthesis, bilateral <1% 63 $1K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 2,585 $1K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 8,302 $1K
87205 <1% 1,207 $1K
J1953 Injection, levetiracetam, 10 mg <1% 380 $1K
J2704 Injection, propofol, 10 mg <1% 2,283 $886.16
70360 <1% 54 $834.60
93880 <1% 12 $812.20
J0360 Injection, hydralazine hcl, up to 20 mg <1% 227 $796.00
82607 <1% 270 $795.74
84156 <1% 685 $774.13
C9113 Injection, pantoprazole sodium, per vial <1% 836 $716.42
J3480 Injection, potassium chloride, per 2 meq <1% 755 $678.82
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 79 $670.81
76857 <1% 29 $611.49
C1769 Guide wire <1% 748 $581.88
99152 <1% 138 $546.71
86780 <1% 86 $505.27
L1830 Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf <1% 12 $482.96
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 320 $439.74
J1940 Injection, furosemide, up to 20 mg <1% 476 $406.79
J0692 Injection, cefepime hydrochloride, 500 mg <1% 132 $385.17
87154 <1% 14 $368.53
80074 <1% 50 $363.68
83550 <1% 251 $342.98
J2800 Injection, methocarbamol, up to 10 ml <1% 358 $322.98
96367 <1% 74 $320.28
83540 <1% 280 $310.23
86592 <1% 28 $302.99
90686 <1% 41 $292.30
74022 <1% 12 $287.36
86920 <1% 48 $284.96
G0008 Administration of influenza virus vaccine <1% 116 $283.27
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 1,068 $282.20
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,793 $242.09
73552 <1% 13 $240.70
71100 <1% 12 $234.50
J0690 Injection, cefazolin sodium, 500 mg <1% 1,006 $191.68
J3360 Injection, diazepam, up to 5 mg <1% 71 $185.24
11045 <1% 509 $182.54
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 50 $177.03
87075 <1% 70 $172.88
84132 <1% 661 $153.86
J2785 Injection, regadenoson, 0.1 mg <1% 29 $153.00
97166 <1% 27 $136.68
J1171 Injection, hydromorphone, 0.1 mg <1% 132 $124.97
97535 Self-care/home management training, each 15 minutes <1% 19 $123.04
73140 <1% 13 $113.44
83615 <1% 64 $112.23
36600 <1% 150 $111.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 14 $94.48
J2470 Injection, pantoprazole sodium, 40 mg <1% 162 $93.93
A9270 Non-covered item or service <1% 18,722 $92.58
88342 <1% 28 $73.78
J2175 Injection, meperidine hydrochloride, per 100 mg <1% 33 $64.29
85018 <1% 672 $59.94
99153 Mod sedat endo service >5yrs <1% 83 $58.50
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,641 $47.18
88304 <1% 282 $45.34
85014 <1% 438 $40.50
J1836 Injection, metronidazole, 10 mg <1% 70 $36.17
G0382 Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) <1% 177 $36.06
J0171 Injection, adrenalin, epinephrine, 0.1 mg <1% 43 $31.60
84550 <1% 32 $27.72
J7626 Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg <1% 24 $25.75
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm <1% 16 $24.23
84520 <1% 31 $21.74
72170 <1% 15 $21.18
85384 <1% 30 $17.37
82565 <1% 27 $14.18
J7644 Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram <1% 30 $10.17
J7060 5% dextrose/water (500 ml = 1 unit) <1% 35 $2.60
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 15 $1.80
G1003 Clinical decision support mechanism medicalis, as defined by the medicare appropriate use criteria program 0% 978 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 509 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 168 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 12 $0.00
15853 0% 29 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 12 $0.00
C1729 Catheter, drainage 0% 95 $0.00
G0384 Level 5 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) 0% 30 $0.00
88312 0% 45 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 33 $0.00
88341 0% 13 $0.00
G0463 Hospital outpatient clinic visit for assessment and management of a patient 0% 63 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 30 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialBAUGHMAN, SONIA (CFO)